Canadian authorities grant product approval for Intercell's Vaccine to prevent Japanese Encephalitis
Intercell AG announced that the Health Canada granted product approval for IXIARO®, the company's vaccine to prevent Japanese encephalitis (JE). According to the company, this decision of the Canadian authorities represents another important milestone for the product's global reach. Intercell's vaccine to prevent Japanese Encephalitis has already been successfully approved and launched in the USA, Europe and Australia.
"We are very pleased that IXIARO is now also approved by the Canadian authorities. This reflects another step in growing our IXIARO business by supplying this important product to travelers", states Gerd Zettlmeissl, Chief Executive Officer of Intercell.
Intercell's Japanese Encephalitis vaccine will be available for the Canadian market by the end of the year and will be distributed and marketed to travel clinics by Novartis Pharmaceuticals Canada Inc. and to the military personnel by Intercell.
IXIARO is a purified, inactivated product for active immunization against infection by the Japanese Encephalitis Virus. IXIARO is manufactured at Intercell's proprietary manufacturing facility in Scotland and is prepared using tissue culture rather than live organisms.
Most read news
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

First trial to prove a diet supplement can prevent hereditary cancer - Could a banana a day keep the cancer doc away?
Battle for HIV drug market share getting fiercer - maybe too fierce for some
Bio Nano Consulting appoints Lord Broers as Chairman of the Board

How a microRNA protects vascular integrity - Hitherto unknown molecular function of a specific microRNA preserves integrity of the endothelium and reduces the risk of atherosclerosis
Blood clotting protein triggers immune attack on the brain
Georg_von_Békésy
